Kucha Winner, Seifu Daniel, Tirsit Abenezer, Yigeremu Mahlet, Abebe Markos, Hailu Dawit, Tsehay Dareskedar, Genet Solomon
Department of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Biochemistry Division of Basic Sciences, University of Global Health Equity, Kigali, Rwanda.
Front Nutr. 2022 Apr 8;9:873900. doi: 10.3389/fnut.2022.873900. eCollection 2022.
Neural tube defects (NTDs) are prevalent congenital defects associated with pre-pregnancy diet with low levels of maternal folate. They are linked to severe morbidity, disability, and mortality, as well as psychological and economic burdens.
The goal of this study was to determine the levels of folate, vitamin B12, and homocysteine in the blood of women who had a pregnancy impacted by NTDs.
A hospital-based case-control study was undertaken between September 2019 and August 2020. The study comprised a total of 100 cases and 167 controls. Enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of folate, vitamin B12, and homocysteine in the serum.
Only 39% of the cases and 54.5% of control mothers reported periconceptional use of folic acid/multivitamin, which indicated a statistically significant difference ( = 0.014). Logistic regression indicated that periconceptional use of folic acid/multivitamin was associated with NTDs ( = 0.015, OR = 1.873, 95% CI: 1.131-3.101). We found that 57% of the cases and 33.5% of controls, as well as 43% of cases and 20.4% of controls had serum folate and vitamin B12 levels below the cut-off value, respectively. Twenty-seven percent of the cases and 6.6% of controls had hyperhomocysteinemia (HHcy). The median concentrations of folate, vitamin B12, and homocysteine in cases and controls were 4.78 and 8.86 ng/ml; 266.23 and 455 pg/ml; 13.43 and 9.7 μmol/l, respectively. The median concentration of folate ( < 0.001) and vitamin B12 ( < 0.001) were significantly lower in the cases than controls, while the homocysteine concentration ( < 0.001) was significantly lower in the controls than cases. Folate [OR (95% CI) = 1.652 (1.226-2.225; = 0.001)], vitamin B12 [OR (95% CI) = 1.890 (1.393-2.565; < 0.001], and homocysteine [OR (95% CI) = 0.191 (0.09-0.405; < 0.001)] levels were associated with NTDs.
Folate and vitamin B12 are deficient in both cases and control mothers. The lower levels of folate and vitamin B12 with an elevated homocysteine level in NTD-affected pregnancy may be an indication that these biochemical variables were risk factors for NTDs. Folate/multivitamin supplementation and/or food fortification should be promoted.
神经管缺陷(NTDs)是常见的先天性缺陷,与孕前饮食中母体叶酸水平低有关。它们与严重的发病率、残疾和死亡率以及心理和经济负担相关。
本研究的目的是确定受NTDs影响妊娠的女性血液中叶酸、维生素B12和同型半胱氨酸的水平。
2019年9月至2020年8月进行了一项基于医院的病例对照研究。该研究共包括100例病例和167例对照。采用酶联免疫吸附测定(ELISA)法测定血清中叶酸、维生素B12和同型半胱氨酸的水平。
只有39%的病例母亲和54.5%的对照母亲报告在受孕前后使用了叶酸/多种维生素,这表明存在统计学显著差异(P = 0.014)。逻辑回归表明,受孕前后使用叶酸/多种维生素与NTDs有关(P = 0.015,OR = 1.873,95%CI:1.131 - 3.101)。我们发现,分别有57%的病例和33.5%的对照、43%的病例和20.4%的对照血清叶酸和维生素B12水平低于临界值。27%的病例和6.6%的对照患有高同型半胱氨酸血症(HHcy)。病例组和对照组中叶酸、维生素B12和同型半胱氨酸的中位数浓度分别为4.78和8.86 ng/ml;266.23和455 pg/ml;13.43和9.7 μmol/l。病例组中叶酸(P < 0.001)和维生素B12(P < 0.001)的中位数浓度显著低于对照组,而对照组中同型半胱氨酸浓度(P < 0.001)显著低于病例组。叶酸[OR(95%CI) = 1.652(1.226 - 2.225;P = 0.001)]、维生素B12[OR(95%CI) = 1.890(1.393 - 2.565;P < 0.001)]和同型半胱氨酸[OR(95%CI) = 0.191(0.09 - 0.405;P < 0.001)]水平与NTDs有关。
病例组和对照母亲均存在叶酸和维生素B12缺乏。在受NTDs影响的妊娠中,叶酸和维生素B12水平较低且同型半胱氨酸水平升高可能表明这些生化变量是NTDs的危险因素。应推广叶酸/多种维生素补充和/或食品强化。